ALS drug edaravone tested for Long-Term safety in small study
NCT ID NCT05568615
First seen Jan 04, 2026 · Last updated May 25, 2026 · Updated 27 times
Summary
This study looked at the safety of an oral form of edaravone for people with ALS, a nerve disease that weakens muscles. Fifteen patients who had already been in earlier studies took the drug for 10 days every two weeks. Researchers tracked side effects to see if the treatment was safe to use over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fukushima Medical University Hospital
Fukushima, Fukushima, 960-1295, Japan
-
Kagawa University Hospital
Kita-gun, Kagawa-ken, 761-0793, Japan
-
Kitasato University Hospital
Sagamihara-shi, Kanagawa, 252-0375, Japan
-
National Epilepsy Center NHO Shizuoka Institute of Epilepsy and Neurological Disorders
Shizuoka, 420-8688, Japan
-
National Hospital Organization Chibahigashi National Hospital
Chiba, Chiba, 260-8712, Japan
-
National Hospital Organization Higashinagoya National Hospital
Nagoya, Aichi-ken, 465-8620, Japan
-
National Hospital Organization Kumamoto Saishun Medical Center
Kōshi, Kumamoto, 861-1196, Japan
-
National Hospital Organization Osaka Toneyama Medical Center
Toyonaka-shi, Osaka, 560-8552, Japan
-
Shiga University of Medical Science Hospital
Ōtsu, Shiga, 520-2192, Japan
-
Tokyo Metropolitan Neurological Hospital
Fuchu-shi, Tokyo, 183-0042, Japan
-
Yokohama City University Hospital
Yokohama, Kanagawa, 236-0004, Japan
Conditions
Explore the condition pages connected to this study.